YDR344C Antibody

What is YDR344C Antibody and what organism does it target?

YDR344C Antibody is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as Baker's yeast. This antibody specifically targets the YDR344C protein (UniProt No. Q05510) and is purified using antigen affinity methods. It is designed for research applications involving S. cerevisiae and comes in liquid form without conjugation .

The antibody is produced using a well-established immunization protocol where rabbits are exposed to the recombinant YDR344C protein from S. cerevisiae. This process generates polyclonal IgG antibodies that recognize multiple epitopes on the target protein, which can be advantageous for certain detection applications in yeast research.

What are the recommended storage conditions for YDR344C Antibody?

Upon receipt, YDR344C Antibody should be stored at either -20°C or -80°C to maintain its activity and specificity. It's crucial to avoid repeated freeze-thaw cycles as these can degrade antibody performance over time . The antibody is supplied in a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4, which helps maintain stability during storage .

For researchers working with this antibody, it's recommended to prepare small working aliquots upon first thaw to minimize the number of freeze-thaw cycles. When handling the antibody, always maintain cold chain practices and use sterile technique to prevent contamination that could compromise experimental results.

What applications has YDR344C Antibody been validated for?

YDR344C Antibody has been tested and validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications . These applications allow researchers to detect and quantify the target protein in various experimental contexts:

• ELISA: Useful for quantitative detection of the target protein in solution

• Western Blotting: Enables visualization of the target protein in cell or tissue lysates, providing information about protein size and relative abundance

It's important to note that the antibody is intended for research use only and should not be used for diagnostic or therapeutic procedures . Before applying this antibody to other detection methods beyond ELISA and WB, researchers should perform validation studies to confirm specificity and sensitivity in their particular experimental system.

How should I design experiments to validate YDR344C Antibody specificity in my yeast strains?

To validate YDR344C Antibody specificity in your specific yeast strains, a multi-faceted approach is recommended:

First, perform Western blot analysis comparing wild-type strains expressing the YDR344C protein with knockout strains or strains where the protein is significantly downregulated. The absence of signal in knockout strains provides strong evidence for antibody specificity . Additionally, include a gradient of protein concentrations to establish detection limits and dynamic range.

Second, implement immunoprecipitation followed by mass spectrometry to identify all proteins pulled down by the antibody. This approach will reveal potential cross-reactivity with other yeast proteins and confirm target engagement .

Third, conduct immunofluorescence microscopy comparing localization patterns with previously published data on YDR344C protein distribution. Discrepancies may indicate off-target binding or issues with antibody performance under fixation conditions.

Finally, consider testing the antibody on closely related yeast species to determine cross-species reactivity, which can be valuable information for comparative studies.

What controls should I include when using YDR344C Antibody in Western blotting experiments?

When using YDR344C Antibody for Western blotting, several controls are essential to ensure experimental validity:

• Positive control: Include purified recombinant YDR344C protein or lysate from wild-type S. cerevisiae (strain ATCC 204508 / S288c) known to express the target protein .

• Negative control: Use lysate from a YDR344C knockout strain or from a different organism that doesn't express homologous proteins.

• Loading control: Probe for a housekeeping protein (e.g., actin or GAPDH) to normalize for differences in sample loading and transfer efficiency.

• Primary antibody omission: Process one membrane section without primary antibody to identify non-specific binding from the secondary antibody.

• Blocking peptide control: Pre-incubate a sample of the antibody with excess immunizing peptide/protein before application to demonstrate that signals can be competed away, confirming specificity.

These controls help distinguish between specific signals and artifacts, increasing confidence in experimental results and facilitating troubleshooting if unexpected results occur.

What is the expected working dilution range for YDR344C Antibody in different applications?

While optimal working dilutions should be determined empirically for each application and experimental system, generally recommended starting dilution ranges for YDR344C Antibody are:

• Western blotting: 1:500 to 1:2000

• ELISA: 1:1000 to 1:5000

These ranges serve as starting points, and titration experiments should be performed to identify the optimal concentration that provides the best signal-to-noise ratio for your specific experimental conditions . Factors that may influence optimal dilution include:

• Sample type and preparation method

• Target protein abundance

• Detection system sensitivity

• Incubation conditions (time, temperature)

• Buffer composition

Consider preparing a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) in your first experiment to identify the concentration that yields the clearest specific signal with minimal background. Document these optimization steps thoroughly to ensure reproducibility in future experiments.

How can I mitigate cross-reactivity issues when studying protein complexes involving YDR344C?

When studying protein complexes involving YDR344C, cross-reactivity can complicate data interpretation. To mitigate these issues, implement the following advanced strategies:

First, perform pre-absorption experiments where the antibody is incubated with proteins suspected of cross-reactivity before use in your assay. This can reduce non-specific binding significantly . Consider using recombinant proteins or purified fractions containing potential cross-reactive proteins.

Second, enhance blocking protocols by using specific blocking agents tailored to your experimental system. While standard blockers (BSA, milk proteins) work for many applications, specialized blockers containing yeast proteins (excluding your target) can reduce background in yeast studies .

Third, implement two-dimensional immunoblotting combining isoelectric focusing with SDS-PAGE to provide higher resolution separation of proteins with similar molecular weights but different isoelectric points. This approach can distinguish between specific and cross-reactive signals more effectively than one-dimensional techniques.

Finally, consider epitope mapping of the YDR344C Antibody to identify the specific regions recognized on the target protein. This information can help predict potential cross-reactivity with structurally similar proteins and guide experimental design to minimize interference .

What approaches can be used to increase detection sensitivity for low-abundance YDR344C protein?

For detecting low-abundance YDR344C protein, several specialized approaches can significantly enhance sensitivity:

• Signal amplification systems: Implement tyramide signal amplification (TSA) or polymer-based detection systems that can increase sensitivity by 10-100 fold compared to conventional detection methods .

• Sample enrichment techniques: Use immunoprecipitation to concentrate the target protein before analysis, or implement subcellular fractionation to isolate compartments where YDR344C is localized, reducing background from other cellular components.

• Enhanced chemiluminescence substrates: Select super-sensitive ECL substrates specifically designed for low-abundance proteins when performing Western blots.

• Optimized blocking and washing: Reduce non-specific binding by testing different blockers (BSA vs. milk vs. commercial alternatives) and implementing more stringent washing steps without compromising specific signals.

• Technological alternatives: Consider using proximity ligation assay (PLA) which can detect single protein molecules through rolling circle amplification, providing dramatically enhanced sensitivity compared to traditional immunodetection methods.

These approaches can be combined for additive or synergistic effects, depending on the specific experimental constraints and the degree of sensitivity required.

How can I assess whether post-translational modifications affect YDR344C Antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition. To assess this for YDR344C Antibody:

First, conduct parallel Western blots with samples treated with specific enzymes that remove common PTMs (phosphatases for phosphorylation, glycosidases for glycosylation, etc.) and compare band patterns and intensities with untreated samples. Shifts in mobility or signal intensity suggest PTM influence on antibody recognition .

Second, perform immunoprecipitation followed by mass spectrometry to identify PTMs present on the captured proteins. Compare the PTM profile of immunoprecipitated proteins with the known PTM landscape of YDR344C to identify potential recognition biases.

Third, test the antibody against recombinant YDR344C proteins with and without specific PTMs, if available. This direct comparison provides the clearest evidence for PTM effects on antibody binding.

Fourth, analyze the immunizing sequence used to generate the antibody and determine whether it contains known PTM sites. Antibodies raised against unmodified peptides may not recognize the modified versions of the same sequence, and vice versa .

Understanding these PTM-related recognition patterns is crucial for accurately interpreting experimental results, especially in studies focusing on protein regulation and modification states.

What are the most common causes of false negative results when using YDR344C Antibody?

False negative results when using YDR344C Antibody can stem from multiple factors. Understanding and addressing these methodologically can improve experimental outcomes:

• Protein denaturation issues: The antibody may recognize conformational epitopes that are destroyed during sample preparation. Try less harsh extraction buffers or native conditions if compatible with your technique .

• Epitope masking: Protein-protein interactions or PTMs may block antibody access to the epitope. Consider alternative lysis conditions, detergents, or denaturing agents to expose hidden epitopes.

• Insufficient protein amount: YDR344C may be expressed at low levels. Increase the amount of starting material or concentrate proteins using precipitation methods before analysis.

• Antibody degradation: Improper storage or handling (repeated freeze-thaw cycles) can reduce antibody activity . Use fresh aliquots and verify antibody functionality with positive controls.

• Incompatible buffers or pH: The antibody may perform optimally within specific buffer conditions. Test alternative buffers, particularly focusing on pH ranges and salt concentrations that might affect antibody-antigen interactions.

• Detection system limitations: The secondary antibody or visualization method may be insufficient. Consider more sensitive detection systems or signal amplification methods as described in section 3.2.

Systematic evaluation of these factors using appropriate controls can help identify the specific cause of false negatives in your experimental system.

How can I optimize fixation and permeabilization conditions for YDR344C Antibody in immunocytochemistry?

Optimizing fixation and permeabilization for immunocytochemistry with YDR344C Antibody requires systematic testing of conditions to preserve both epitope accessibility and cellular architecture:

For fixation, compare:

• Paraformaldehyde (2-4%): Preserves structure but may mask some epitopes

• Methanol/acetone: Better for certain nuclear or cytoskeletal proteins

• Glyoxal: Alternative to PFA with potentially better epitope preservation

• Hybrid protocols: Brief PFA followed by methanol can combine advantages

For permeabilization, test:

• Triton X-100 (0.1-0.5%): Standard but may disrupt membranes excessively

• Saponin (0.1-0.25%): Milder, reversible permeabilization

• Digitonin (10-50 μg/ml): Selective for plasma membrane permeabilization

• Freeze-thaw cycles: Physical permeabilization that can preserve epitopes

Create a matrix of conditions, testing each fixative with each permeabilization method. Evaluate results based on:

• Signal intensity at expected localization sites

• Background level

• Preservation of cellular morphology

• Reproducibility across samples

Document optimal conditions, including precise timing, temperature, and buffer compositions to ensure protocol reproducibility .

What strategies can resolve high background issues when using YDR344C Antibody in immunoassays?

High background is a common challenge when working with antibodies like YDR344C. Several methodological approaches can effectively reduce background while preserving specific signals:

• Optimize blocking protocols: Test different blocking agents (BSA, casein, commercial blockers) and concentrations (1-5%). For yeast studies, consider using extracts from knockout strains as specialized blockers to absorb cross-reactive antibodies .

• Antibody dilution optimization: Titrate primary and secondary antibodies separately to find the minimum concentration that maintains specific signal while reducing background. Sometimes counterintuitively, too concentrated antibody solutions can increase non-specific binding .

• Buffer composition adjustments: Increase salt concentration (150-500 mM NaCl) or add mild detergents (0.05-0.1% Tween-20) to washing and antibody dilution buffers to disrupt weak, non-specific interactions.

• Extended washing protocols: Implement more frequent changes of wash buffer or longer washing times between incubation steps. Consider gentle agitation during washes to improve efficiency.

• Secondary antibody cross-adsorption: Use secondary antibodies that have been cross-adsorbed against proteins from the species under study to minimize cross-species reactivity .

• Sample pre-clearing: Incubate samples with unconjugated beads or irrelevant antibodies of the same species and isotype as your primary antibody to remove components that bind non-specifically.

Document changes systematically to identify which modifications most effectively reduce background in your specific experimental system.

How does YDR344C Antibody compare to other antibodies targeting yeast proteins in terms of specificity and sensitivity?

Comparing YDR344C Antibody to other yeast-targeting antibodies reveals important considerations for experimental design:

Unlike commercial antibodies against commonly studied yeast proteins (e.g., actin, tubulin, or Pma1), YDR344C Antibody targets a more specialized protein with fewer validation studies in the literature. Researchers should therefore implement more rigorous validation procedures as outlined in section 2.1 .

The antigen affinity purification method used for YDR344C Antibody provides better specificity than crude serum but may not match the homogeneity of monoclonal antibodies or recombinant antibody fragments . When extremely high specificity is required for distinguishing between closely related proteins, techniques like CRISPR epitope tagging may be preferable to using the native antibody.

For quantitative applications, researchers should be aware that lot-to-lot variation may be greater with polyclonal antibodies like YDR344C compared to monoclonal alternatives, necessitating careful calibration across experiments using different antibody lots .

What approaches enable accurate quantification of YDR344C protein levels in comparative studies?

Accurate quantification of YDR344C protein levels in comparative studies requires careful methodological consideration:

First, establish a standardized protein extraction protocol specifically optimized for YDR344C to ensure consistent recovery across samples. This includes standardizing cell disruption methods, buffer composition, and inhibitor concentrations to minimize variable protein degradation or extraction efficiency.

Second, implement absolute quantification using a calibration curve with purified recombinant YDR344C protein. This approach allows expression of results in absolute units (ng/ml or molecules/cell) rather than relative units, enabling more meaningful cross-study comparisons .

Third, utilize multiplex detection systems where YDR344C and loading control proteins are simultaneously detected with spectrally distinct fluorophores. This approach eliminates variation introduced by stripping and reprobing membranes and allows direct normalization within each lane .

Fourth, consider stable isotope labeling approaches (SILAC, TMT, iTRAQ) combined with mass spectrometry for the most accurate comparative quantification, especially when antibody-based detection shows limitations in linearity or specificity.

Finally, implement statistical validation including technical and biological replicates with appropriate statistical tests to determine significance. For small changes in expression (<2-fold), more replicates may be needed to achieve statistical power .

How can YDR344C Antibody be used in conjunction with advanced microscopy techniques for protein localization studies?

YDR344C Antibody can be powerfully combined with advanced microscopy techniques to reveal detailed protein localization patterns:

For super-resolution microscopy (STORM, PALM, STED), the YDR344C Antibody can be directly labeled with photo-switchable fluorophores or used with appropriately labeled secondary antibodies. These techniques can resolve protein distributions beyond the diffraction limit, potentially revealing previously undetectable suborganelle localizations of YDR344C. When implementing these approaches, careful attention to sample preparation is critical to minimize background fluorescence .

For live-cell imaging applications, consider developing genetically encoded tags that can be recognized by fragment antibodies derived from YDR344C. This approach allows visualization of dynamic processes without fixation artifacts while maintaining the specificity advantages of antibody-based detection.

In correlative light and electron microscopy (CLEM), YDR344C Antibody can be conjugated to both fluorescent tags and electron-dense particles, enabling precise localization from macroscopic to ultrastructural scales. This approach is particularly valuable for proteins that form discrete complexes or associate with specific subcellular structures.

For multiplexed protein detection, consider cyclic immunofluorescence or mass cytometry approaches where YDR344C Antibody is used in sequential staining rounds or conjugated to metal isotopes, respectively. These techniques allow simultaneous localization of dozens of proteins in the same sample, providing rich contextual information about protein interaction networks .

When designing these experiments, validate that labeling strategies do not interfere with antibody binding specificity, and optimize fixation and permeabilization protocols specifically for the microscopy technique being employed.

Table of YDR344C Antibody Specifications and Applications

This comprehensive table provides researchers with the essential specifications for YDR344C Antibody, facilitating experimental design and troubleshooting across various applications. Researchers should verify current specifications with the manufacturer before beginning critical experiments.